NCT00285285

Brief Summary

To compare the effect of "point-of-care" (POC) analysis of blood work with traditional laboratory methods on length of stay in a pediatric emergency department (PED).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2004

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2004

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2004

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

January 31, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 1, 2006

Completed
Last Updated

February 1, 2006

Status Verified

January 1, 2006

First QC Date

January 31, 2006

Last Update Submit

January 31, 2006

Conditions

Keywords

Point-of-care TestingPediatric Emergency DepartmentLength of StayEfficiency

Outcome Measures

Primary Outcomes (1)

  • Total Length of Stay

Secondary Outcomes (1)

  • Time length for results return, disposition decision, time in ED proper

Interventions

Eligibility Criteria

Age1 Day - 21 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Clinically requiring bloodwork capable by the POC device

You may not qualify if:

  • Requiring other bloodwork such as medication levels, WBC

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

DehydrationSeizuresGastroenteritisHyperglycemia

Condition Hierarchy (Ancestors)

Water-Electrolyte ImbalanceMetabolic DiseasesNutritional and Metabolic DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsGastrointestinal DiseasesDigestive System DiseasesGlucose Metabolism Disorders

Study Officials

  • M. Douglas Baker, MD

    Yale University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 31, 2006

First Posted

February 1, 2006

Study Start

January 1, 2004

Study Completion

August 1, 2004

Last Updated

February 1, 2006

Record last verified: 2006-01